AMA, AARP Back FTC In Pay-For-Delay Antitrust Fight

Law360, New York (January 30, 2013, 7:00 PM ET) -- The American Medical Association, AARP and others on Tuesday backed the Federal Trade Commission's bid to overturn a ruling holding so-called pay-for-delay pharmaceutical patent settlements to be legal, warning the U.S. Supreme Court that leaving the antitrust standard in place could devastate consumers.

In a joint amicus brief, the interest groups focused on the billions of dollars the settlements will allegedly cost consumers in the coming years, urging the justices to overturn the Eleventh Circuit's holding that the Hatch-Waxman Act settlements are generally legal as long...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required